Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024 @accessiblemeds
Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024  @accessiblemeds
Uploaded April 2024 | Updated November 2026, 3 hours ago
October 21-23, 2024 | Rockville, Maryland
GRx+Biosims 2024 is the leading scientific, regulatory, and policy event for the U.S. generics and biosimilars industry. We are excited to announce that top officials and subject-matter experts, including Dr. Jacqueline Corrigan-Curray, Dr. Iilun Murphy, Dr. Sarah Yim, and Dr. Elizabeth Miller from FDA, will be sharing their knowledge and best practices. Join us for a special session reflecting on the remarkable career of Dr. Janet Woodcock, who recently retired from FDA. The GRx+Biosims learning tracks will feature timely discussions and insights relevant to technical, regulatory, and policy professionals. Gain insights to enhance your understanding of succeeding in generic and biosimilar development, regulatory processes and approvals, and the evolving policy landscape.

Learn more and register today: grxbiosims.org
Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024Teva USA is #RemarkablyGenericAAM All Access - Build Back Better w/ Kurt Karst, Rachel Turow, and Rachel GoodeSavings from Biosimilars in 2021 #GRxBiosimsSavingsReportAAMs Christine Simmon Talks About Biosimilar Programming at GRx+Biosims 2019AAM Member Fresenius Kabi: Rachel GoodeCREATES Act - Its Time to Level the Playing FieldMark Cuban - AAM Access! 2023Protect & Expand CompetitionAAM Member Fresenius Kabi: Fabrice RomanetGeneric Drug Prices vs. Brand Drug PricesAAM All Access - Robert Pollock
Association for Accessible Medicines |

Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER